Novel pyridine compounds

Details for Australian Patent Application No. 2006204159 (hide)

Owner AstraZeneca AB

Inventors O'Sullivan, Michael F.; Harvey, Darren Martin; Brickmann, Kay; Cheng, Leifeng; Giordanetto, Fabrizio; Bach, Peter; Groneberg, Robert D.; Zetterberg, Fredrik; Bostrom, Jonas

Agent Davies Collison Cave

Pub. Number AU-A-2006204159

PCT Pub. Number WO2006/073361

Priority 0521484.6 21.10.05 GB; 0500140.9 06.01.05 GB

Filing date 4 January 2006

Wipo publication date 13 July 2006

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 213/78 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/073361 Priority application(s): WO2006/073361

7 February 2008 Amendment Made

  The nature of the amendment is: Amend the names of the co-inventors to add Osterlund, Krister

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204161-Derivatives of isothiazol-3(2H)-one 1,1-dioxides as Liver X Receptor modulators

2006204146-Biomarkers for identifying efficacy of tegaserod in patients with chronic constipation